595 related articles for article (PubMed ID: 3014472)
1. Restoration of varicella-zoster virus cell-mediated immune response after varicella booster vaccination.
Berger R; Luescher D; Just M
Postgrad Med J; 1985; 61 Suppl 4():143-5. PubMed ID: 3014472
[TBL] [Abstract][Full Text] [Related]
2. Delayed hypersensitivity skin test to detect susceptibility to varicella and zoster.
Berger R; Luescher D; Just M; D'Hondt E; Bogaert H
Postgrad Med J; 1985; 61 Suppl 4():137-41. PubMed ID: 3014471
[TBL] [Abstract][Full Text] [Related]
3. Loss of varicella zoster virus antibodies despite detectable cell mediated immunity after vaccination.
Ludwig B; Kraus FB; Allwinn R; Keim S; Doerr HW; Buxbaum S
Infection; 2006 Aug; 34(4):222-6. PubMed ID: 16896582
[TBL] [Abstract][Full Text] [Related]
4. Varicella-zoster virus-specific cellular immunity in subjects given acyclovir after household chickenpox exposure.
Kumagai T; Kamada M; Igarashi C; Yuri K; Furukawa H; Chiba S; Kojima H; Saito A; Okui T; Yano S
J Infect Dis; 1999 Sep; 180(3):834-7. PubMed ID: 10438374
[TBL] [Abstract][Full Text] [Related]
5. Decline in varicella-zoster virus (VZV)-specific cell-mediated immunity with increasing age and boosting with a high-dose VZV vaccine.
Levin MJ; Smith JG; Kaufhold RM; Barber D; Hayward AR; Chan CY; Chan IS; Li DJ; Wang W; Keller PM; Shaw A; Silber JL; Schlienger K; Chalikonda I; Vessey SJ; Caulfield MJ
J Infect Dis; 2003 Nov; 188(9):1336-44. PubMed ID: 14593591
[TBL] [Abstract][Full Text] [Related]
6. Vaccination of children with malignant disease against varicella.
Slørdahl SH; Wiger D; Strømøy T; Degre M; Thørsby E; Lie SO
Postgrad Med J; 1985; 61 Suppl 4():85-92. PubMed ID: 3014484
[TBL] [Abstract][Full Text] [Related]
7. Varicella vaccination in HIV-1-infected children after immune reconstitution.
Bekker V; Westerlaken GH; Scherpbier H; Alders S; Zaaijer H; van Baarle D; Kuijpers T
AIDS; 2006 Nov; 20(18):2321-9. PubMed ID: 17117018
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of varicella zoster virus-specific cell-mediated immunity by using an interferon-γ enzyme-linked immunosorbent assay.
Hayashida K; Ozaki T; Nishimura N; Gotoh K; Funahashi K; Nakane K; Gomi Y; Manabe S; Ishikawa T; Yamanishi K
J Immunol Methods; 2015 Nov; 426():50-5. PubMed ID: 26232696
[TBL] [Abstract][Full Text] [Related]
9. Immunogenicity of a two-dose regime of varicella vaccine in children with cancers.
Leung TF; Li CK; Hung EC; Chan PK; Mo CW; Wong RP; Chik KW
Eur J Haematol; 2004 May; 72(5):353-7. PubMed ID: 15059071
[TBL] [Abstract][Full Text] [Related]
10. T lymphocyte cytotoxicity with natural varicella-zoster virus infection and after immunization with live attenuated varicella vaccine.
Diaz PS; Smith S; Hunter E; Arvin AM
J Immunol; 1989 Jan; 142(2):636-41. PubMed ID: 2536059
[TBL] [Abstract][Full Text] [Related]
11. OKA-SK-RIT Varicella vaccine for "primary" and for booster vaccinations.
Just M; Berger R; Luescher D
Dev Biol Stand; 1982; 52():381-3. PubMed ID: 6299847
[TBL] [Abstract][Full Text] [Related]
12. Live varicella immunization in healthy non-immune nurses.
Ndumbe PM; Cradock-Watson JE; Heath RB; Levinsky RJ
Postgrad Med J; 1985; 61 Suppl 4():133-5. PubMed ID: 3014470
[TBL] [Abstract][Full Text] [Related]
13. Measurement of varicella-zoster virus (VZV)-specific cell-mediated immunity: comparison between VZV skin test and interferon-gamma enzyme-linked immunospot assay.
Sadaoka K; Okamoto S; Gomi Y; Tanimoto T; Ishikawa T; Yoshikawa T; Asano Y; Yamanishi K; Mori Y
J Infect Dis; 2008 Nov; 198(9):1327-33. PubMed ID: 18774884
[TBL] [Abstract][Full Text] [Related]
14. Low induction of varicella-zoster virus-specific secretory IgA antibody after vaccination.
Terada K; Niizuma T; Yagi Y; Miyashima H; Kataoka N; Sadahiro T
J Med Virol; 2000 Sep; 62(1):46-51. PubMed ID: 10935988
[TBL] [Abstract][Full Text] [Related]
15. Varicella-zoster virus-specific, cell-mediated immunity with interferon-gamma release assay after vaccination of college students with no or intermediate IgG antibody response.
Terada K; Itoh Y; Fujii A; Kitagawa S; Ogita S; Ouchi K
J Med Virol; 2015 Feb; 87(2):350-6. PubMed ID: 25080078
[TBL] [Abstract][Full Text] [Related]
16. Stimulation of specific immune response to varicella antigens in the elderly with varicella vaccine.
Duchateau J; Vrijens R; Nicaise J; D'Hondt E; Bogearts H; Andre FE
Postgrad Med J; 1985; 61 Suppl 4():147-50. PubMed ID: 3014473
[TBL] [Abstract][Full Text] [Related]
17. Immunogenicity of Oka/Merck varicella vaccine in children vaccinated at 12-14 months of age versus 15-23 months of age.
Silber JL; Chan IS; Wang WW; Matthews H; Kuter BJ
Pediatr Infect Dis J; 2007 Jul; 26(7):572-6. PubMed ID: 17596796
[TBL] [Abstract][Full Text] [Related]
18. Cellular and Humoral Responses to a Second Dose of Herpes Zoster Vaccine Administered 10 Years After the First Dose Among Older Adults.
Levin MJ; Schmader KE; Pang L; Williams-Diaz A; Zerbe G; Canniff J; Johnson MJ; Caldas Y; Cho A; Lang N; Su SC; Parrino J; Popmihajlov Z; Weinberg A
J Infect Dis; 2016 Jan; 213(1):14-22. PubMed ID: 26452397
[TBL] [Abstract][Full Text] [Related]
19. Varicella-zoster virus-specific cell-mediated immunity in subjects with herpes zoster.
Otani N; Yamanishi K; Sakaguchi Y; Imai Y; Shima M; Okuno T
J Immunol Methods; 2012 Mar; 377(1-2):53-5. PubMed ID: 22261191
[TBL] [Abstract][Full Text] [Related]
20. [Varicella zoster virus vaccine--a review].
Petersen CS; Buhl MR; Heilmann CJ
Ugeskr Laeger; 1997 Feb; 159(8):1081-5. PubMed ID: 9072851
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]